ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of M200 (Volociximab) in Patients With Metastatic Renal Cell Carcinoma (RCC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00100685
Recruitment Status : Terminated
First Posted : January 5, 2005
Last Update Posted : April 27, 2012
Sponsor:
Information provided by (Responsible Party):
Abbott

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : December 2007
  Actual Study Completion Date : December 2007